Bio-Rad Says MJ Research Will Push Overall Double-Digit Sales Growth in Fourth Quarter | GenomeWeb

The addition of MJ Research and new product launches should propel Bio-Rad Laboratories — or at least its life sciences unit — to double-digit sales growth in the fourth quarter, Bio-Rad said last week.

“The joining of forces with MJ Research is a move that really expands our offering in the DNA-amplification market,” Norman Schwartz, CEO of Bio-Rad, told investors and analysts in a conference call to discuss its results for the quarter ending Sept. 30. “This is exciting for us; it’s a large growing market with lots of areas to participate in.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.